Drawing for READY A RANDOMIZED TRIAL EVALUATING THE ADDITION OF DASATINIB TO DOCETAXEL THERAPY

USPTO serial 77723943

READY A RANDOMIZED TRIAL EVALUATING THE ADDITION OF DASATINIB TO DOCETAXEL THERAPY

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
BRODSKY, AARON
Law office
TMO LAW OFFICE 110

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with READY A RANDOMIZED TRIAL EVALUATING THE ADDITION OF DASATINIB TO DOCETAXEL THERAPY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human useACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2009MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Jul 9, 2009DOCKASSIGNED TO EXAMINER
Jul 9, 2009ABN1ABANDONMENT - EXPRESS MAILED
Jul 8, 2009EXARTEAS EXPRESS ABANDONMENT RECEIVED
May 1, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2009NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance